More from this Publisher
More from this Publisher
Related Documents
-
Notice: Human drugs:
New drug applications— Premarket approval applications; list; safety and effectiveness summaries’ availability
111 reads -
Notice: Human drugs:
New drug applications— Industry Exchange Workshop on Food and Drug Administration Clinical Trial Requirements
48 reads -
Notice: Human drugs:
Drug products withdrawn from sale for reasons other than safety or effectiveness— ACIPHEX (rabeprazol sodium)
73 reads -
Notice: Human drugs:
New drug applications— Penthrane (methoxyflurane) Inhalation Liquid, 99.9 percent; approval withdrawn
98 reads -
Notice: Human drugs: Prescription drug user fee cover sheet (FDA Form 3397) and user fee payment identification number; electronic availability
150 reads -
Notice: Meetings: Pulmonary-Allergy Drugs Advisory Committee
98 reads -
E7-19349
78 reads -
Notice: Meetings: Application user fees for combination products
77 reads -
Notice: Harmonisation International Conference; guidelines availability: Biotechnological/biological products; Q5E comparability subject to changes in manufacturing process
80 reads -
Notice: Human drugs: Cardiovascular and Renal Drugs Advisory Committee
54 reads -
Notice: Harmonisation International Conference; guidelines availability: Blood Products Advisory Committee
40 reads -
Notice: Medical devices:
Patent extension; regulatory review period determinations— Endocrinologic and Metabolic Drugs Advisory Committee
69 reads -
Notice: Human drugs:
New drug applications— Psychopharmaceutical Drugs Advisory Committee
82 reads -
Notice: Meetings: Science Board
61 reads -
Notice: Meetings: Cardiovascular and Renal Drugs Advisory Committee
87 reads -
Notice: Meetings: Medical Devices Advisory Committee
52 reads -
Notice: Center for Food Safety and Applied Nutrition; program priorities:
138 reads -
Notice: Grants and cooperative agreements; availability, etc.: Antiviral drug development; conducting virology studies and submitting data to agency
65 reads -
Notice: Meetings: Prescription Drug User Fee Act
44 reads
Related Documents
Flag this document
2 Pages
